Cashu | News | GUD.TO

HomeWatchlistNewsSignalsPicks

DJI

-0.10%

SPX

+0.02%

IXIC

+0.15%

FTSE

-0.64%

N225

-0.97%

AXJO

-0.41%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Stocks

Health Care

gud.to

Knight Therapeutics Inc

TSX: GUD.TO

-0.02 (-0.31%)

6.52

USD

At close at Aug 26, 15:03 UTC

Latest Knight Therapeutics Inc News

Knight Closes US$50 Million Revolving Credit Facility with NBC

Transcript : Knight Therapeutics Inc., Sumitomo Pharma America Holdings, Inc. - M&A Call

Knight Therapeutics and Sumitomo Pharma Enter into Exclusive Licensing Agreements to Commercialize Sumitomo?S Canadian Portfolio

Knight Therapeutics And Sumitomo Pharma Enter Into Exclusive Licensing Agreements To Commercialize Sumitomo'S Canadian Portfolio

Knight Therapeutics and Sumitomo Pharma enter into Exclusive Licensing Agreements to commercialize Sumitomo’s Canadian Portfolio

Knight Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025

Knight Therapeutics Inc. announces voting results from the Annual General Meeting

Knight Therapeutics : 2024 Annual Report Management Information Circular

Knight Therapeutics : 2024 Annual Report Annual Information

Knight Therapeutics : Fourth Quarter 2024 Financial Statements

Latest Cashu News

Knight Therapeutics Secures $50 Million Credit Facility for Growth and Acquisitions

Knight Therapeutics Inc. Secures $50 Million Credit Facility for Strategic Growth and Acquisitions

Knight Therapeutics Inc. Expands Portfolio with Exclusive Licensing Agreement with Sumitomo Pharma